Literature DB >> 18266781

An international collaborative study to establish the 2nd World Health Organization International Standard for hepatitis B virus DNA nucleic acid amplification technology-based assays.

S A Baylis1, A B Heath, M Chudy, G Pisani, A Klotz, S Kerby, W Gerlich.   

Abstract

BACKGROUND AND OBJECTIVES: The aim of this study was to replace the 1st World Health Organization International Standard for hepatitis B virus DNA for nucleic acid amplification technique (NAT)-based assays (code 97/746) with a new International Standard. Two lyophilized preparations freeze dried from the same bulk were evaluated in the original collaborative study (coded 97/746 and 97/750, and termed AA and BB, respectively, in the original study). This present study re-evaluates these two preparations in terms of potency and real-time stability.
MATERIALS AND METHODS: The 1(st) International Standard (97/746) and the second lyophilized preparation (97/750) were coded Samples 1 and 2, respectively, in the present study. The samples were distributed to six laboratories and assayed on four separate occasions. Accelerated thermal degradation samples of the two preparations were examined after long-term storage at 4 degrees C and 20 degrees C for more than 51 months.
RESULTS: Data were returned from a total of nine different NAT-based assays, five in qualitative format and four in quantitative format. The results of this study confirm the results of the original collaborative study, with no significant differences being found in estimated international units (IU)/ml or polymerase chain reaction-detectable units/ml for the 1(st) International Standard (Sample 1 in this study) and the proposed replacement preparation, Sample 2 (97/750). Real-time and accelerated degradation studies indicate that both samples are very stable. Storage of both preparations at 20 degrees C for more than 51 months resulted in no detectable degradation.
CONCLUSIONS: On the basis of the data presented in this collaborative study, Sample 2 (code 97/750) was established as the 2nd International Standard for hepatitis B virus DNA for NAT-based assays with a potency of 10(6) IU/ml (500,000 IU/vial).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18266781     DOI: 10.1111/j.1423-0410.2008.01023.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  11 in total

1.  Alanine aminotransferase is an inadequate surrogate marker for detecting lamivudine resistance.

Authors:  Lee Guan Lim; Myat Oo Aung; Bee Leng Seet; Cindy Tan; Yock Young Dan; Yin Mei Lee; Dede Selamat Sutedja; Mark Fernandes; Guan Huei Lee; Evelyn Koay; Seng Gee Lim
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

Review 2.  Standardization of Nucleic Acid Tests: the Approach of the World Health Organization.

Authors:  S A Baylis; P Wallace; E McCulloch; H G M Niesters; C M Nübling
Journal:  J Clin Microbiol       Date:  2019-01-02       Impact factor: 5.948

3.  Enhancement of PCR Detection Limit by Single-Tube Restriction Endonuclease-PCR (RE-PCR).

Authors:  Sibnarayan Datta; Raghvendra Budhauliya; Soumya Chatterjee; Vijay Veer; Runu Chakravarty
Journal:  Mol Diagn Ther       Date:  2016-06       Impact factor: 4.074

4.  Effectiveness of hepatitis B virus vaccination program in Egypt: Multicenter national project.

Authors:  Iman I Salama; Samia M Sami; Zeinab Nabil Ahmed Said; Manal H El-Sayed; Lobna A El Etreby; Thanaa M Rabah; Dalia M Elmosalami; Amany T Abdel Hamid; Somaia I Salama; Aida M Abdel Mohsen; Hanaa M Emam; Safaa M Elserougy; Amal I Hassanain; Naglaa F Abd Alhalim; Fatma A Shaaban; Samia A Hemeda; Nihad A Ibrahim; Ammal M Metwally
Journal:  World J Hepatol       Date:  2015-10-08

Review 5.  An overview of occult hepatitis B virus infection.

Authors:  Zeinab Nabil Ahmed Said
Journal:  World J Gastroenterol       Date:  2011-04-21       Impact factor: 5.742

Review 6.  Rapid and quantitative detection of hepatitis B virus.

Authors:  Yue-Ping Liu; Chun-Yan Yao
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

7.  Occult hepatitis B virus infection among Egyptian blood donors.

Authors:  Zeinab N Said; Manal H El Sayed; Iman I Salama; Enas K Aboel-Magd; Magda H Mahmoud; Maged El Setouhy; Faten Mouftah; Manal B Azzab; Heidi Goubran; Amal Bassili; Gamal E Esmat
Journal:  World J Hepatol       Date:  2013-02-27

Review 8.  Standardization of NAT for Blood-Borne Pathogens.

Authors:  Sally A Baylis; Michael Chudy; C Micha Nübling
Journal:  Transfus Med Hemother       Date:  2015-07-01       Impact factor: 3.747

Review 9.  Occult HBV infection: a faceless enemy in liver cancer development.

Authors:  Jaime Morales-Romero; Gustavo Vargas; Rebeca García-Román
Journal:  Viruses       Date:  2014-04-08       Impact factor: 5.048

10.  Complete Genome Sequence of the WHO International Standard for Hepatitis B Virus DNA.

Authors:  Adrian Jenkins; Rehan Minhas; Clare Morris; Neil Berry
Journal:  Genome Announc       Date:  2017-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.